跳至主要内容
临床试验/JPRN-UMIN000000532
JPRN-UMIN000000532已完成未知

PB-01(intravenous immunoglobulin)therapy for patients with pemphigus unresponsive to corticosteroids:Multi-center,Randomized,Double-Blind ,Placebo Control,Parallel Assignment Study to examine dose response and efficacy of NPB-01.(Phase2+3) - Dose response and efficacy confirmatory study of NPB-01 for patients with pemphigus unresponsive to corticosteroids.

IHON PHARMACEUTICAL CO.,LTD0 个研究点目标入组 75 人开始时间: 2006年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients treated with Plasmapheresis 2)Patients treated with corticosteroids pulse therapy (methylpredonizolone over 0.5g/day) 3)Patients received intravenous immunoglobulin 4) Patients with history of shock for NPB-01 5)Patients with history of Hypersensitivity for NPB-01 6)Patients with IgA deficiency 7)Patients with impaired liver function 8)Patients with impaired renal function 9)Patients with cerebro- or cardiovascular disorders or a history of these disorders 10)Patients with a high risk of thromboembolism

研究者

发起方
IHON PHARMACEUTICAL CO.,LTD

相似试验

PB-01(intravenous immunoglobulin)therapy for... | 临床试验